Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$1.07 - $1.5 $11,236 - $15,751
10,501 Added 27.4%
48,826 $68,000
Q3 2021

Nov 12, 2021

BUY
$1.35 - $2.16 $15,974 - $25,559
11,833 Added 44.67%
38,325 $63,000
Q3 2020

Nov 13, 2020

BUY
$2.87 - $5.95 $9,049 - $18,760
3,153 Added 13.51%
26,492 $118,000
Q2 2020

Aug 13, 2020

BUY
$1.52 - $3.63 $35,475 - $84,720
23,339 New
23,339 $71,000

About IMV Inc.


  • Ticker IMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,452,200
  • Description
  • IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...
More about IMV
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.